Interferential Current Therapy After Total Knee Arthroplasty

May 30, 2018 updated by: Mehmet Resul KADI, Ege University

Is Interferential Current Effective in the Management of Pain, Range of Motion, Edema Following Total Knee Arthroplasty Surgery?: Randomized Double-blind Controlled Trial

Interferential current is widely used as a popular treatment in painful musculoskeletal disorders. And total knee arthroplasty patients present with extreme pain immediately after surgery. So this study is aimed to investigate the effectiveness of interferential current implementation following total knee arthroplasty surgery. In this study interferential current compared with sham interferential current . Patients were assessed with pain, range of motion , edema and the amount of used paracetamol.

Study Overview

Detailed Description

A total of 132 patients ranging in 60-85 years who were undergoing their first total knee arthroplasty due to knee OA were recruited into a randomized, double-blind, prospective and controlled study. Participants were recruited at the Orthopedics and Traumatology inpatient clinic. The patients were seen postoperative first day and were assigned to receive either interferential current or sham interferential current by block randomization. After the procedure was explained to each subject, interferential current treatment was applied 2 times for 5 days, each treatment was continued approximately 30 minutes. Four electrodes were used to deliver quadripolar interferential current Subjects were told that in order to produce an effect, the intensity of the stimulator must be maintained at a "strong but comfortable level" at all times. The sham interferential current treatment consisted of the placement of the same pads for the same time but no electrical stimulation was applied to the probes. At the same time, all patients received standard postoperatively rehabilitation program. Patients were assessed with pain, range of motion , edema and the amount of used paracetamol.

Study Type

Interventional

Enrollment (Actual)

113

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bornova
      • İzmir, Bornova, Turkey, 35030
        • Ege University School of Medicine Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

•Patients who underwent total knee arthroplasty surgery

Exclusion Criteria:

  • Patients who had experienced of any electrotherapy prior to the TKA to be sure blinding of therapy
  • Patients who had history of any contraindication for electrotherapy
  • Patients who had chronic pain rather than knee OA
  • Patients who had experienced a known or suspected joint infection or a specific condition (ie, peripheral or central nervous system lesions, neoplasm, diabetes mellitus, osteonecrosis, recent trauma and pacemaker)
  • Patients who had history of stroke, central nervous disease, mental impairment or poor general health status that would interfere with functional assessments during the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Interferential Current Treatment
Interferential Current group received interferential current treatment 30 minutes, 2 times a day for 5 days after the surgery.
SHAM_COMPARATOR: Sham Interferential Current Treatment
In the sham interferential Current treatment, no electrical stimulation was applied to the probes with the same pads for the same time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pain from baseline measured by visual analog scale
Time Frame: Change in pain measured 5th and 30th days after surgery
Pain intensity that was measured by visual analog scale (minimum score:0; maximum score:100)(higher values represent worse outcome)
Change in pain measured 5th and 30th days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Range of Motion from baseline
Time Frame: Change of Range of Motion measured 5th and 30th days after surgery
The measurement of the range of the motion was performed by a goniometer of active extension and flexion (higher values represent better outcome)
Change of Range of Motion measured 5th and 30th days after surgery
Change of Edema from baseline
Time Frame: Change of Edema measured 5th and 30th days after surgery
Edema as a change in circumference from the preoperative value was measured by a meter (higher values represent worse outcome)
Change of Edema measured 5th and 30th days after surgery
Amount of used paracetamol
Time Frame: 5th and 30th days after surgery
the paracetamol intake was recorded as gr. (higher values represent worse outcome)
5th and 30th days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: mehmet r kadı, MD, Ege University School of Medicine
  • Study Director: Simin Hepguler, prof, Ege University School of Medicine
  • Study Chair: Funda C Atamaz, prof, Ege University School of Medicine
  • Study Chair: Emine Dede, md, Ege University School of Medicine
  • Study Chair: Semih Aydogu, prof, Ege University School of Medicine
  • Study Chair: Kemal Aktuğlu, prof, Ege University School of Medicine
  • Study Chair: Nadir Ozkayın, prof, Ege University School of Medicine
  • Study Chair: Cihat Ozturk, prof, Ege University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 9, 2014

Primary Completion (ACTUAL)

September 1, 2015

Study Completion (ACTUAL)

September 1, 2015

Study Registration Dates

First Submitted

May 7, 2018

First Submitted That Met QC Criteria

May 30, 2018

First Posted (ACTUAL)

June 1, 2018

Study Record Updates

Last Update Posted (ACTUAL)

June 1, 2018

Last Update Submitted That Met QC Criteria

May 30, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • TKP35IF

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Knee Arthroplasty

Clinical Trials on Interferential Current

3
Subscribe